The benefits and side effects of gadolinium-based contrast agents in multiple sclerosis patients

The benefits and side effects of gadolinium-based contrast agents in multiple sclerosis patients

Saved in:

Bibliographic Details
Format:	Digital revista
Language:	English
Published:	Associação Médica Brasileira 2022
Online Access:	http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302022000800979
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

SYNTHESIS AND CHARACTERIZATION OF GADOLINIUM-BASED NANOCRYSTALS FOR THEIR POTENTIAL APPLICATION AS TRIMODAL IMAGING CONTRAST AGENTS
by: Rashid,Haroon Ur, et al.
Published: (2020)

Incidence of nephrogenic systemic fibrosis after adoption of restrictive gadolinium-based contrast agent guidelines
by: Prando,Adilson
Published: (2011)

Gadolinium-Derived Contrast Agents Hypersensitivity: Retrospective Characterization of a Portuguese Cohort
by: Silva,Maria Inês T., et al.
Published: (2023)

Chemometric-Assisted Hydrophilic Interaction Chromatographic Method for the Determination of Gadolinium-Based Magnetic Resonance Imaging Contrast Agent in Liposomes
by: Maia,Ana Luiza C., et al.
Published: (2018)

Effects of iodinated contrast agent, xylocaine and gadolinium concentration on the signal emitted in magnetic resonance arthrography: a samples study
by: Silva,Yvana Lopes Pinheiro da, et al.
Published: (2015)

Psychiatric manifestations in multiple sclerosis patients and multiple sclerosis in psychiatric patient
by: Fragoso,Yára Dadalti, et al.
Published: (2009)

Gadolinium(III) complexes with N-Alkyl-N-methylglucamine surfactants incorporated into liposomes as potential MRI contrast agents.
by: SILVA, S. R., et al.
Published: (2016-01-25)

Assessment of patients with multiple sclerosis according to tests of the Multiple Sclerosis Functional Composite
by: Figueiredo,Anelise Ineu, et al.
Published: (2016)

Telangiectasias bleeding in patient with multiple sclerosis
by: Martínez-Caselles,Alejandro, et al.
Published: (2011)

Olfactory alterations in patients with multiple sclerosis
by: Jordy,Sergio Semeraro, et al.
Published: (2016)

Psychiatric disorders in multiple sclerosis patients
by: Fazzito,Mirella Martins, et al.
Published: (2009)

Musical identity of patients with multiple sclerosis
by: Moreira,Shirlene Vianna, et al.
Published: (2009)

Migraine in 746 patients with multiple sclerosis
by: Fragoso,Yara Dadalti, et al.
Published: (2019)

Pharmacogenomic study in patients with multiple sclerosis
by: Bustamante, Marta F., et al.
Published: (2015-10)

The effect of social support on the quality of life of patients with multiple sclerosis
by: Costa,David Castro, et al.
Published: (2012)

An initial investigation of serum cytokine levels in patients with gadolinium retention
by: Maecker,Holden T., et al.
Published: (2020)

The effect of multiple sclerosis on the professional life of a group of Brazilian patients
by: Fragoso,Yára Dadalti, et al.
Published: (2010)

Determinants of disability development in patients with multiple sclerosis
by: Kara,Fatma, et al.
Published: (2021)

High levels of alexithymia in patients with multiple sclerosis
by: Eboni,Audred Cristina Biondo, et al.
Published: (2018)

Toxic effects of mercury, lead and gadolinium on vascular reactivity
by: Vassallo,D.V., et al.
Published: (2011)

Effects of Comorbid Fibromyalgia Syndrome on activities of daily living in multiple sclerosis patients
by: ULUSOY,Ersin Kasım
Published: (2020)

Global adherence to pharmacotherapeutic treatment in patients with multiple sclerosis
by: Ballester Martínez,N, et al.
Published: (2021)

Disability and progression in Afro-descendant patients with multiple sclerosis
by: Aurenção,Juliana Calvet Kallenbach, et al.
Published: (2016)

Patients with multiple sclerosis present low levels of empathy
by: Almeida,Marcos Barbosa de, et al.
Published: (2016)

Serum YKL-40 levels in patients with multiple sclerosis
by: Dönder,Ahmet, et al.
Published: (2021)

Cognitive profile of patients with relapsing remitting multiple sclerosis
by: ANDRADE,VIVIAN M., et al.
Published: (1999)

Natalizumab adverse events are rare in patients with multiple sclerosis
by: Fragoso,Yára Dadalti, et al.
Published: (2013)

Prevalence of temporomandibular disorders symptoms in patients with multiple sclerosis
by: Carvalho,Lucas S. C., et al.
Published: (2014)

Coping strategies and mood profiles in patients with multiple sclerosis
by: Milanlioglu,Aysel, et al.
Published: (2014)

Suicidal ideation, anxiety, and depression in patients with multiple sclerosis
by: Tauil,Carlos Bernardo, et al.
Published: (2018)

Late onset multiple sclerosis: concerns in aging patients
by: Lotti,Claudia Beatriz de Campos, et al.
Published: (2017)

Neurofilament light chain in the assessment of patients with multiple sclerosis
by: DOMINGUES,Renan Barros, et al.
Published: (2019)

Multiple sclerosis risk perception and acceptance for Brazilian patients
by: Bichuetti,Denis Bernardi, et al.
Published: (2018)

DNA damage and postural balance in multiple sclerosis patients
by: Menezes,Karla Mendonça, et al.
Published: (2017)

Gadolinium substitution effect on the thermomagnetic properties of Ni ferrite ferrofluids
by: Jacobo, Silvia Elena, et al.
Published: (2016)

How to choose initial treatment in multiple sclerosis patients: a case-based approach
by: Apóstolos,Samira Luisa Pereira, et al.
Published: (2022)

Dynamic gadolinium injection in the assessment of enchondromas
by: Canella,Clarissa
Published: (2013)

Real-world effectiveness of natalizumab treatment in patients with relapsing multiple sclerosis in Argentina and Chile
by: Ysrraelit,Maria Celica, et al.
Published: (2021)

Anesthetic management of a patient with multiple sclerosis - case report
by: Zuccolotto,Eduardo Barbin, et al.
Published: (2016)

Epidemiological profile in multiple sclerosis patients, Uberaba, MG, Brazil
by: Grzesiuk,Anderson Kuntz
Published: (2011)

Resource Map